Search results for

Two of Asia's biggest names in IP have joined together to form a new specialized practice in Singapore. IP law firm Ella Cheong & G Mirandah and patent and trade mark attorneys Spruson & Ferguson Pte Ltd, the Singapore branch of Australia's Spruson & Ferguson, will be launched formally on June 6. But the new firm, Ella Cheong Mirandah & Sprusons, is already open for business. The link between the two Singapore firms was announced during the AIPPI congress in Melbourne in the last week of March. It is expected that all staff from Sprusons's Singapore office and from Ella Cheong & G Mirandah will join the new set-up. Cheong is retiring as a partner of Wilkinson & Grist, the Hong Kong law firm, and will chair Ella Cheong Mirandah & Sprusons.

A recent High Court decision on copyright infringement has demonstrated the importance of distinguishing the author of a work from the rightful copyright owner of the work. As copyright is not registrable in many countries including Singapore, the locus standi to sue for copyright infringement does not stem from a simple registration certificate. It is always paramount to trace the copyright from the author of the work to the plaintiff in order to ensure that the latter has the requisite capacity to sue.

CANADA: Percy Schmeiser, a 70-year old farmer, lost a patent infringement suit against Monsanto Canada. Monsanto claimed Schmeiser infringed the GM Canola patent by growing and selling crops from seeds blown into his garden. UK: A British court ruled in favour of Amgen in its patent infringement suit against Roche Holding and Transkaryotic Therapies (TKT). Roche and TKT were held to infringe the Epogen patents in the UK. US: Fruit of the Loom is accusing competitor Gildan Activewear of stealing trade secrets. Fruit of the Loom alleges that former manager Elizabeth Walton passed critical documents to her ex-employer David Cherry. US: Jupiter Media Metrix reached a settlement in its patent infringement suit forcing PC Data out of the business of tracking internet usage. Jupiter also filed suits against two other competitors, NetValue and NetRatings, for patent infringement. Jupiter was represented by Daniel R Harris of Brobeck, Phleger & Harrison. US: Monsanto and Aventis Crop Science settled two lawsuits against each other and agreed to avoid patent roadblocks to the development of genetically improved cotton varieties. Part of the settlement includes cross-licensing under existing cotton transformation patents. US: Pfizer filed a trade mark suit against Lara Williams for using the name Niagara for a fizzy drink. Pfizer contends Niagara is being promoted as Viagra for women. US: Pharmacia filed a trade mark suit against Alcon Laboratories for selling a competing drug with a similar name. Pharmacia allege their drug Xalatan has been harmed by Alcon naming its glaucoma drug Travatan. US: PrimeTime 24 Joint Venture lost its Supreme Court appeal against the National Football League to transmit NFL games to customers in Canada. PrimeTime argued that federal copyright law did not apply outside the US, but the Court held the company's actions violated NFL's copyright. US: Savin Corporation won its preliminary injunction against Main Street Copier & Fax Repair, who operated websites under domain names, incorporating trade names owned by Savin. Savin was represented by David A Einhorn, Andrea Pincus and James M Andriola of Anderson Kill & Olick. US: SunTrust Bank won its suit against Alice Randall for copyright infringement, over her book The Wind Done Gone. SunTrust bank accused Randall of infringing the copyright of the classic novel Gone with the Wind. US: Twelve major Hollywood studios won their case against RecordTV.com, which must pay the studios $50,000 (£35,714) in legal costs. Robert Schwartz of O'Melveny & Myers in Los Angeles represented the studios.

Fittingly, I am writing this column on April 26 ? the first World Intellectual Property Day. Today, which will become an annual celebration, is the date when the Convention establishing WIPO entered into force in 1970.

A new set of amendments to the Patent Law of the People’s Republic of China will enter into force in July 2001. Elizabeth Chien-Hale examines the revisions to the compulsory licensing provisions

To a packed courtroom on Thursday April 19, 39 drug companies agreed to drop their lawsuit against the South African government.

Tony Samuel, in the third of three articles on intellectual property value issues, considers some of the questions arising from the enormous growth in the worth of media and sponsorship rights in sport

Patent infringement litigation involves a large number of uncertainties. Alexander I Poltorak and Paul J Lerner reveal how to calculate the risk involved

Jeremy Phillips looks again at the function of trade marks in the light of three cases which are heading towards the ECJ

BRAZIL: Merck slashed prices of two AIDS drugs, just days after threatening to take Brazil's state-owned pharmaceutical firm Far-Manguinhos to court for violating the patent on an AIDS drug. Brazil has agreed to halt its plans to challenge the patent. CHINA: Cable TV, the sole provider of pay-TV programmes in China, is urging the Chinese government to outlaw the possession of unauthorized decoders openly on sale in Shenzhen. The Broadcasting Ordinance forbids the manufacture and sale of decoders but does not forbid unauthorized viewing. CHINA: Philips Electronics is to invest $1 in a new assembly and test plant in China. CHINA: A senior manager of the Unilever group is in custody after being accused of helping a local firm to produce fake Unilever products. CHINA: The government is to pass legislation to extend copyright protection to cover the internet, and bring its legislation in to line with developed countries. CHINA: People in Hebei in China will be rewarded up to 10% of the amount of the fines imposed if they report the production or sale of fake or inferior goods to anti-counterfeiting departments. CZECH REPUBLIC: Czech brewer Budejovicky Budvar, which has a long-running trade mark dispute with Anheuser-Busch, has relinquished rights to the Budweiser name in the US. Budvar will adopt Czechvar as the brand name for its product in the American beer market. JAPAN: The first dispute over internet domain names in an Asian alphabet has ruled in favour of Japanese Pharmaceutical company Sankyo. WIPO ordered the immediate transfer of the two-character Japanese name which corresponds to sankyo.com. SWEDEN: From May 7, Skriptor, changs its name to Compu-Mark Nordic for its trade mark searching activities but will function under the Skriptor name for its name creation activities. UK: Three people were convicted for their part in a multi-million pound software counterfeit scam to defraud Microsoft. The fraudsters received jail sentences of 10 years. US: Abbott Laboratories plans to sell its two AIDS drugs at no profit in sub-Saharan Africa. The drugs will be sold for less than $1000 each. In the US they sell for $7,100. US: EMI and Bertelsmann joined together to launch a new subscription-based music service on the web called MusicNet. RealNetworks is bringing its internet media technology into the partnership. MusicNet will be available later this year. The companies will license the platform to companies wanting to sell music subscription services on the web including Napster. US: Mylan Laboratories and Watson Pharmaceuticals received approval from US regulators to market generic forms of the drug BuSpar, ending a four-month patent dispute with Bristol-Myers Squibb. US: Versign will keep the right to register dot-com names until 2007. It will give up control of dot-org after 2002 and submit dot-net for re-bidding in early 2006. The changes still need to be agreed by the US Commerce Department. US: Embattled song-swap company Napster has licensed revolutionary digital fingerprinting technology to help it filter out copyrighted songs from its service to comply with a federal court order. US: Federal antitrust enforcers are preparing civil charges against Schering-Plough and generic companies Upsher-Smith of Minneapolis, and the Lederle unit of American Home Products. Charges allege patent settlements between the companies including illegal payments of $90 million to delay a low-cost generic drug from reaching the market.